# Novacyl, St Fons, France – FDA Inspections

Source: https://www.keypedia.com/companies/novacyl/928b015a-ee45-4383-ad21-070b43308727

> Inspection records and compliance data for Novacyl in St Fons. 3 FDA inspections on record, last inspected November 24, 2023.

---

## Details

- Name: Novacyl
- FEI Number: 3002807997
- Business Operations: API MANUFACTURE
- Address Line 1: Usine De St Fons Chimie, Rue Prosper Monnet
- City: St Fons
- Country Name: France
- Address: Usine De St Fons Chimie, Rue Prosper Monnet, St Fons, France
- Country: France

## Related Documents

- FDA Inspection 1245783 - Novacyl - 2023-11-24 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 24, 2023
- FDA Inspection 1245783 - Novacyl - 2023-11-24 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 24, 2023
- [EIR - Novacyl - 2018-02-02](https://www.keypedia.com/records/eir/novacyl/7581af91-e42d-4395-847b-39d332fdea14) — source: FDA, date: February 2, 2018
- FDA Inspection 1045747 - Novacyl - 2018-02-02 — source: FDA, date: February 2, 2018
- FDA Inspection 805212 - Novacyl - 2012-10-25 — classification: No Action Indicated (NAI), source: FDA, date: October 25, 2012

## Related Companies

- [Livzon Group (Ningxia) Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/livzon-group-ningxia-pharmaceutical-co-ltd/78a1f9d4-41d0-440a-87bc-8c9521d0159a)
- [PolyPeptide Laboratories, Inc.](https://www.keypedia.com/companies/polypeptide-laboratories-inc/9d05664c-4a42-45cc-81f6-ef85c356ecc1)
- [Bachem Americas, Inc.](https://www.keypedia.com/companies/bachem-americas-inc/3a9656ad-737b-4682-9ab3-951b1041002e)
- [Zhejiang Jiuzhou Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/zhejiang-jiuzhou-pharmaceutical-co-ltd/6ff21ff3-4c18-4e07-9c38-79e499bfb8fa)
- [Shandong Xinhua Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/shandong-xinhua-pharmaceutical-co-ltd/acea3619-5739-4a9f-a4b2-82e0207194b3)
- [Cosma SPA](https://www.keypedia.com/companies/cosma-spa/14f96eaf-912e-4eed-af27-43ec40d9b7b7)
- [Dottikon Exclusive Synthesis AG](https://www.keypedia.com/companies/dottikon-exclusive-synthesis-ag/db7bdf8b-bd88-416f-94f2-62f946e90074)
- [Livzon New North River Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/livzon-new-north-river-pharmaceutical-co-ltd/49cdcdc8-9c6c-4486-b6cd-e404c21dd2d2)
- [BioSpectra, Inc.](https://www.keypedia.com/companies/biospectra-inc/ffb13a38-4f04-49cb-a6fe-fd55f544fcf0)
- [Cambrex Charles City, Inc.](https://www.keypedia.com/companies/cambrex-charles-city-inc/b14d342b-e5ae-4df6-ad7a-39cd62dfb9c6)

## Related Officers

- [company_representative](https://www.keypedia.com/people/carinne-saroli/0fb73846-1117-4306-8e06-f16783c05185)
- [recipient](https://www.keypedia.com/people/robert-monti/1269a2a4-9828-410b-b158-a3ff1e09005b)
